Quantcast

Posts related to ‘CTIC’

Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)

Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be.  It often traded huge volume around drug approval or study news, and shares ...
Read Full Story »

24/7 Wall St. Closing Bell (BAC, CHK, SAM, ERJ, PAA, GE, MCD, KMB, ALK, ALTR, COF, HBI, SNDK, KEY, AEP, CP, CTIC, RCL, PCX, RVBD, RMBS)

Markets opened higher this morning although a decline in tech stocks weighed on the Nasdaq, leaving the index with only a small gain going into the last hour of trading. ...
Read Full Story »

24/7 Wall St. Closing Bell (AAPL, ADP, KFT, PG, MCO, LULU, ADGF, CHTP, AEO, BWS, CSIQ, CTIC, HOV, TRCR, MAG, BONT, P, VRML)

US stocks opened higher this morning following an in-line report from ADP on US employment gains. There was little economic news out today, but we can anticipate tomorrow’s report on ...
Read Full Story »

24/7 Wall St. Closing Bell (CHK, WYN, CMCSA, RL, DELL, CEG, ENB, SPWR, HNZ, CPB, DMD, BDCO, CTIC, GILD, SCON)

US stocks opened mixed this morning, with the Nasdaq opening lower than both the DJIA and the S&P 500. The Nasdaq briefly crossed into positive territory this morning, but has ...
Read Full Story »

Morning Movers (CTIC, RAIL, GILD, SCON, SPWR, STP, FSLR)

Two of the three major US equities indexes opened higher this morning with the Nasdaq composite being the laggard. The gains are modest due to any news from Europe on ...
Read Full Story »

24/7 Wall St. Closing Bell (K, SPLS, TWX, AAP, AZO, JPM, GCI, SIFY, WEN, ONB, GTXI, PBY, TNB, CTIC, PMC)

All three major indexes opened lower again today on weak markets in both Europe and Asia. European markets continued to be weighed down by the lack of a firm agreement ...
Read Full Story »

Morning Movers (GTXI, PBY, TNB, CTIC, PMC)

There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share prices. These include GTX Inc. (NASDAQ: GTX), Pep Boys -- ...
Read Full Story »

Morning Movers (LIVE, CTIC, ADGE, CSKI, BONE)

There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share prices. These include LiveDeal Inc. (NASDAQ: LIVE), Cell Therapeutics Inc. ...
Read Full Story »

24/7 Wall St. Closing Bell (C, SHLD, SIRI, YHOO, MCP, FGP, TITN, OPTT, KMGB, DMND, BCSI, FLOW, PCYC, CTIC, GE)

Equity markets opened higher this morning as an agreement on dealing with the Eurozone’s debt crisis boosted markets. Shares climbed during the day, recovering some of the losses in yesterday’s ...
Read Full Story »

24/7 Wall St. Closing Bell (MO, VZ, TSO, LNKD, GE, CHKR, BTH, PBY, UEC, AZO, DRI, TOL, LQDT, DMND, SAI, VRA, FRO, CTIC, CRK, VG, HL)

Equities opened a little weaker this morning, but by 10:00 a.m. markets had turned slightly positive and have remained in positive territory for the rest of the day. The gain ...
Read Full Story »

24/7 Wall St. Top Analyst Calls of the Week (BK, BEAM, CTIC, CSCO, DMD, FSLR, GE, GS, RAX, S, VPRT, AAPL)

Each morning 24/7 Wall St. compiles a summary of the analyst upgrades, downgrades and initiations seen from Wall St. research firms that are having an impact on stocks. At the ...
Read Full Story »

Top Analyst Upgrades & Downgrades (ALTR, BK, BRCM, CTIC, CLWR, COP, DG, GFI, HTS, KR, NTES, NVAX, RAX)

These are some of this Thursday's top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Altera Corporation (NASDAQ: ALTR) Cut to Neutral at Baird. Bank ...
Read Full Story »

Key Secondary Offerings Impacting Stocks (AHT, CTIC, SYNM, SKT)

The impact of secondary offerings is being felt this morning.  Some key deals announced are from Ashford Hospitality Trust, Inc. (NYSE: AHT), Cell Therapeutics, Inc. (NASDAQ: CTIC), Syntroleum Corporation ...
Read Full Story »

Rethinking Cell Therapeutics… As An Acquirer? (CTICD)

Cell Therapeutics, Inc. (NASDAQ: CTICD) has long been a controversial stock.  It has brought many rewards for investors and it has also brought much pain to investors.  We recently featured ...
Read Full Story »

BioWatch: Cell Therapeutics Versus FDA, Before ASCO (CTICD)

Cell Therapeutics, Inc. (NASDAQ: CTICD) has been very active since its recent 1-for-6 reverse stock split took place on May 16, 2011.  Its share volume has increased on all but ...
Read Full Story »